/MDCXW
MDCXW Stock - Medicus Pharma Ltd.
Healthcare|BiotechnologyNASDAQ
$0.81-4.16%
$0.03 (-4.16%) • Dec 19
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.10
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.89
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MDCXW
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.80 – $0.81
TARGET (TP)$0.93
STOP LOSS$0.74
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-1.98
52W High$2.50
52W Low$0.81
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A |
| Operating Income | $-11,180,902 | $-4,729,945 | $-978,416 | $-1,441,388 |
| Net Income | $-11,155,516 | $-5,314,765 | $-1,692,382 | $-2,055,263 |
| Net Margin | N/A | N/A | N/A | N/A |
| EPS | $-0.90 | $-0.67 | $-0.34 | $-1.09 |
Company Overview
Medicus Pharma Ltd. is a clinical-stage biotech company focused on accelerating the development of novel therapeutic assets. Their lead subsidiary, SkinJect Inc., is developing a non-invasive treatment for basal cell carcinoma using a dissolvable microneedle patch to deliver chemotherapeutic agents directly to tumor cells.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MDCXWBeat Rate
33%
Last 3 quarters
Avg Surprise
-44.1%
EPS vs Estimate
Beats / Misses
1/2
Last 12 quarters
Latest EPS
$-0.86
Q4 2025
EPS Surprise History
Q2 25
-68.5%
$-0.42vs$-0.25
Q3 25
-72.9%
$-0.43vs$-0.25
Q4 25
+9.2%
$-0.86vs$-0.94
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | $-0.94 | $-0.86 | +9.2% | ✓ BEAT |
Q3 2025 | Aug 12, 2025 | $-0.25 | $-0.43 | -72.9% | ✗ MISS |
Q2 2025 | May 14, 2025 | $-0.25 | $-0.42 | -68.5% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about MDCXW
What is MDCXW's current stock price?
Medicus Pharma Ltd. (MDCXW) is currently trading at $0.81 per share. The stock has moved -4.16% today.
What is the analyst price target for MDCXW?
No analyst price targets are currently available for this stock.
What sector is Medicus Pharma Ltd. in?
Medicus Pharma Ltd. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is MDCXW's market cap?
Medicus Pharma Ltd. has a market capitalization of $0.02 billion, making it a small-cap company.
Does MDCXW pay dividends?
No, Medicus Pharma Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCUE
Cue Biopharma, Inc.
$0.27
Mkt Cap: $0.0B
FBIO
Fortress Biotech, Inc.
$3.54
Mkt Cap: $0.1B
HOWL
Werewolf Therapeutics, Inc.
$0.69
Mkt Cap: $0.0B
ICCC
ImmuCell Corporation
$5.97
Mkt Cap: $0.1B
INKT
MiNK Therapeutics, Inc.
$11.59
Mkt Cap: $0.1B
IOBT
IO Biotech, Inc.
$0.66
Mkt Cap: $0.0B
NRXP
NRx Pharmaceuticals, Inc.
$2.37
Mkt Cap: $0.0B
OSTX
OS Therapies Incorporated
$1.54
Mkt Cap: $0.1B
OTLK
Outlook Therapeutics, Inc.
$2.01
Mkt Cap: $0.1B
SPRB
Spruce Biosciences, Inc.
$78.74
Mkt Cap: $0.0B
Explore stocks similar to MDCXW for comparison